Supplementary materials (6).docx (51.59 kB)
Cost-effectiveness Analysis of Prolonged-Release Fampridine to Treat Walking Disability of Multiple Sclerosis in China - Supplementary materials
dataset
posted on 2022-07-27, 09:46 authored by Xinran Zhao, Han Yang, Tian Wei, Jin Zhao, Jun Liu, Zhe Huang, Lin Zhu, Yinan Zhao, Wei Li
Discussion Guides prepared for the interview with
Multiple Sclerosis Related Clinical KOL
July 2021
